CHRISTOPHER GEORGEFF: Open Payments
NPI 1093225229 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,303 in 206 payments from 19 companies in 2025. Trend: 2023 $3,076 · 2024 $3,308 · 2025 $3,303
Food & beverage: $3,032Education: $272
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $510 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $379 |
| GENZYME CORPORATION | 17 | $374 |
| Janssen Biotech, Inc. | 15 | $332 |
| Novartis Pharmaceuticals Corporation | 18 | $230 |
| Galderma Laboratories, L.P. | 28 | $216 |
| Amgen Inc. | 8 | $202 |
| Regeneron Healthcare Solutions, Inc. | 9 | $200 |
| UCB, Inc. | 15 | $161 |
| E.R. Squibb & Sons, L.L.C. | 8 | $156 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, ILUMYA, RINVOQ, NEMLUVIO, OTEZLA, COSENTYX.
Industry payments across NC — which companies pay providers there.
